Clinical Trials
7 trialsNCT04594772 2026-06-01
Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma
University of Cincinnati
Phase 2 Active not recruiting
NCT04589234 2026-05-14
Saltikva for Metastatic Pancreatic Cancer
Salspera LLC
Phase 2 Active not recruiting
NCT04469556 2026-02-20
PASS-01
University Health Network, Toronto
Phase 2 Completed
NCT05360732 2025-11-13
Redefining FOLFIORINOX in Older Pancreatic Cancer Patients
Fox Chase Cancer Center
Phase 2 Active not recruiting
NCT07208539 2025-10-06
ZSPAC-14
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT03563248 2025-10-01
Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT05132504 2025-07-18
Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
Baylor College of Medicine
Phase 2 Recruiting